Giant Biogene Holding Co., Ltd. (2367.HK) HKSE
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Giant Biogene Holding Co., Ltd.
Sector
Consumer Defensive
Industry
Household & Personal Products
Employees
1758
First IPO Date
November 04, 2022
Key Executives
| Name | Title | Pay | Year Born |
| Jianya Yan | Chief Executive Officer & Executive Chairman of the Board | 880,277 | 1966 |
| Yubo Yan | Chief Product Officer, Joint Company Secretary & Executive Director | 419,290 | 1996 |
| Huijuan Zhang | Chief Financial Officer & Executive Director | 1.14M | 1987 |
| Juan Ye | Senior Vice President & Executive Director | 1.15M | 1972 |
| Juan Fang | Senior Vice President & Executive Director | 1.15M | 1974 |
| Nelly Au-Yeung | Joint Company Secretary | 0 | N/A |
| Yajuan Yan | Senior Vice President | 0 | 1970 |
| Zhiguang Duan | Senior Vice President | 0 | 1982 |
| Daidi Fan | Chief Scientific Officer | 0 | 1967 |
Description
Giant Biogene Holding Co., Ltd. operates as an investment holding entity, primarily engaged in the research, development, production, and sale of beauty and wellness products based on bioactive materials throughout the People's Republic of China. The company also manufactures functional foods leveraging rare ginsenosides technology and provides medical devices. Its diverse product range, which includes specialized skincare, medical dressings, and nutritional supplements, is marketed predominantly under brand names such as Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan. Established in 2000, Giant Biogene Holding Co., Ltd. maintains its headquarters in Xi'an, PRC.
